Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Axid
  2. Axid AR
  3. Axid Pulvules
  4. Heartburn Relief
  5. Pepcid
  6. Pepcid AC
  7. Tagamet
  8. Tagamet HB
  9. Zantac
  10. Zantac 150
  11. Zantac 150 Efferdose
  12. Zantac 25

Canadian Brand Name

  1. Alti-Ranitidine
  2. Apo-Cimetidine
  3. Apo-Famotidine
  4. Famotidine

Descriptions


Histamine H2-receptor antagonists, also known as H2-blockers, are used to treat duodenal ulcers and prevent their return. They are also used to treat gastric ulcers and for some conditions, such as Zollinger-Ellison disease, in which the stomach produces too much acid. In over-the-counter (OTC) strengths, these medicines are used to relieve and/or prevent heartburn, acid indigestion, and sour stomach. H2-blockers may also be used for other conditions as determined by your doctor.

H2-blockers work by decreasing the amount of acid produced by the stomach.

H2-blockers are available both over-the-counter (OTC) and with your doctor's prescription.

Limited testing has found unacceptable levels of a probable human carcinogen, N-nitrosodimethylamine (NDMA), in some ranitidine medicines.

This product is available in the following dosage forms:

  • Tablet
  • Solution
  • Powder for Suspension
  • Capsule

From Mayo Clinic to your inbox

Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health. Click here for an email preview.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Portions of this document last updated: Nov. 01, 2023